Roivant Sciences (ROIV) Minority Interest (2021 - 2026)
Roivant Sciences (ROIV) posted Minority Interest of $765.0 million for Q1 2026, up 8.52% on a QoQ basis from $705.0 million in Q4 2025, and up 53.13% year-over-year from $499.6 million in Q1 2025.
Roivant Sciences (ROIV) Minority Interest (2021 - 2026) Analysis & Trends
Roivant Sciences' Minority Interest history runs 6 years deep, the most recent figure standing at $765.0 million for Q1 2026.
- Quarterly Minority Interest rose 53.13% year-over-year to $765.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $765.0 million (up 53.13% YoY) and the FY2026 annual result came in at $765.0 million, up 53.13% from the prior year.
- Minority Interest was $765.0 million for Q1 2026 at Roivant Sciences, up from $705.0 million in the prior quarter.
- Across five years, Minority Interest topped out at $765.0 million in Q1 2026 and bottomed at $22.5 million in Q1 2022.
- A 5-year average of $443.1 million and a median of $446.5 million in 2023 frame the typical range for Minority Interest.
- Annual changes were most pronounced in 2023 — Minority Interest jumped 1900.0% — and 2024, when it decreased 29.97%.
- Roivant Sciences' Minority Interest stood at $353.5 million in 2022, then soared by 39.96% to $494.8 million in 2023, then dropped by 29.97% to $346.5 million in 2024, then soared by 103.46% to $705.0 million in 2025, then climbed by 8.52% to $765.0 million in 2026.
- Business Quant data shows ROIV's Minority Interest at $765.0 million in Q1 2026, $705.0 million in Q4 2025, and $443.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Roivant Sciences | 24.16 Bn | 24.16 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 765.04 Mn |
| Dec 31, 2025 | 704.97 Mn |
| Sep 30, 2025 | 443.13 Mn |
| Jun 30, 2025 | 470.27 Mn |
| Mar 31, 2025 | 499.59 Mn |
| Dec 31, 2024 | 346.50 Mn |
| Sep 30, 2024 | 427.09 Mn |
| Jun 30, 2024 | 459.98 Mn |
| Mar 31, 2024 | 479.95 Mn |
| Dec 31, 2023 | 494.82 Mn |
| Sep 30, 2023 | 377.10 Mn |
| Jun 30, 2023 | 423.41 Mn |
| Mar 31, 2023 | 449.82 Mn |
| Sep 30, 2022 | 353.55 Mn |
| Jun 30, 2022 | 371.28 Mn |
| Mar 31, 2022 | 22.49 Mn |
| Dec 31, 2021 | 22.49 Mn |
| Sep 30, 2021 | 22.49 Mn |
| Jun 30, 2021 | 22.49 Mn |
| Mar 31, 2021 | 22.49 Mn |